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Abstract N-myristoyltransferase (NMT) is essential for the
survival of eukaryotes and the production of infectious human
immunode¢ciency virus type-1(HIV-1) by the host cell. In this
study, we found decreases in the mRNA levels of human NMT
isoforms and the NMT activities in the course of HIV-1 infec-
tion in the human T-cell line, CEM. Investigating the cytotoxic
e¡ect of the novel synthetic NMT inhibitors on the chronic
HIV-1 infected T-cell line, CEM/LAV-1, and the uninfected
CEM, revealed that the cytotoxic e¡ect was signi¢cantly selec-
tive for CEM/LAV-1. This was thought to be due to the di¡er-
ence between the NMT levels of the cell lines. In this paper, we
propose that NMT may be a candidate target for anti-HIV-1-
infected-cell agents. , 2002 Federation of European Biochem-
ical Societies. Published by Elsevier Science B.V. All rights
reserved.
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1. Introduction
Highly active anti-retroviral therapy (HAART) has been a
successful means of markedly reducting viremia in human
immunode¢ciency virus type-1 (HIV-1)-infected individuals,
and has led to a reduction of the mortality rate of patients
with acquired immunode¢ciency syndrome in recent years
[1,2]. However, the therapeutic strategy, which involves block-
age of steps of the viral life cycle, cannot completely eradicate
the virus from infected individuals. Even though the HIV-1
RNA level in blood becomes undetectable during HAART,
the virus is capable of reactivation of productive infection
following cessation of the therapy, which indicates that induc-
ible HIV-1 latent reservoirs exist during HAART [3^5]. It has
been estimated that the reservoir may be stable for up to
60 years during HAART [6].
N-myristoyltransferase (NMT) (EC 2.3.1.9.7) catalyzes the
covalent attachment of myristate to the N-terminal Gly resi-
due of various proteins, the modi¢cation of which is called
N-myristoylation. Since the disruption of NMT expression
was found to cause recessive lethality and developmental de-
fects in Saccharomyces cerevisiae [7] and Drosophila [8], re-
spectively, NMT appears to be essential for the survival of
eukaryotes. NMT also plays a very important role in HIV-1
replication, because the N-termini of viral proteins, p17gag and
Nef, are N-myristoylated [9^12], which is indispensable for
conferring infectivity [13,14] and the e¡ective replication of
HIV-1 [15,16]. It is therefore thought that human NMT
(hNMT) is a potential target of anti-HIV-1 agents, whereas
inhibition of hNMT activity may damage the host cell.
Previously, we reported that the expression level of hNMT
was decreased in acute and chronic HIV-1-infected human
T-cell line CEM cells [17]. In this study, the mRNA levels
of hNMT isoforms and the activity of NMT in acute HIV-
1-infected CEM cells were measured. Consistent with the pro-
¢le of the expression level of the protein, both levels decreased
partially but signi¢cantly during the process of HIV-1 infec-
tion. Novel synthetic NMT inhibitors, i.e. serinal derivatives
[18], exhibited a signi¢cantly selective cytotoxic e¡ect on
chronic HIV-1-infected cells, CEM/LAV-1, and the di¡erence
in selectivity between CEM and CEM/LAV-1 cells was
thought to be due to their NMT expression levels. The strat-
egy of speci¢cally targeting HIV-1-infected cells with an NMT
inhibitor may contribute to eradicating the HIV-1 reservoir in
these patients.
2. Materials and methods
2.1. Materials
The reagents used in the study were obtained from the following
sources: the RPMI-1640 medium and Dulbecco’s modi¢ed Eagle’s
medium (DMEM) were from Nissui Seiyaku Co. (Tokyo, Japan);
N-myristoyl serinal bisul¢te, O-myristoyl serinal bisul¢te, N-acetyl-
O-palmitoyl serinal diethylacetal, and N-acetyl-O-myristoyl serinal di-
ethylacetal were gifts from Dr. S. Ikeda (Torii and Co., Ltd., Tokyo,
Japan).
2.2. Cell culture and HIV-1 preparation
A human T-cell line, CEM, and a chronically HIV-1-infected T-cell
line, CEM/LAV-1, were maintained as previously described [19]. A
human colon adenocarcinoma cell line, COLO320DM, was cultured
at 37‡C in DMEM supplemented with 5% fetal calf serum (100 IU/ml
penicillin and 100 Wg/ml streptomycin) in 5% CO2.
Preparation of infectious HIV-1 (LAV-1 strain) and titration of
infectivity were performed as previously described [20].
2.3. Acute HIV-1 infection
CEM cells (2U105 cells/ml, 10 ml) were infected with HIV-1 at a
multiplicity of infection (m.o.i.) of 0.25, incubated for 1 h at 37‡C in
5% CO2, washed twice with PBS(^), and resuspended in the RPMI-
1640 medium. The cells were incubated for 0, 24, 48, 72 or 96 h at
37‡C in 5% CO2 and subjected to NMT^enzyme-linked immunosor-
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bent assay (ELISA) and reverse transcriptase (RT)-PCR. Cell viability
was determined by the trypan blue dye exclusion method.
2.4. Cell lysis and NMT^ELISA
CEM cells (7.5U105) were lysed with lysis bu¡er (10 mM Tris^HCl
(pH 7.4), 10 mM EDTA, 0.5% Triton X-100, 1 mM 4-(2-aminoethyl)
benzenesulfonyl £uoride, 0.1 mM N-K-p-tosyl-L-lysine chloromethyl
ketone, 0.1 mM N-K-p-tosyl-L-phenylalanine chloromethyl ketone,
2 Wg/ml leupeptin, 2 Wg/ml pepstatin A). After centrifugation at
15 000 rpm for 5 min, the supernatants were used for NMT^ELISA
as previously described [21].
2.5. Semiquantitative RT-PCR
Total RNA isolation from the cells was performed using a Quick-
Prep Total RNA Extraction kit (Amersham Pharmacia Biotech UK,
Ltd.) in accordance with the manufacturer’s instructions. The total
RNA (0.5 Wg) was reverse transcribed to cDNA using MuLV RT
according to the instructions enclosed in the Gene Amp RNA PCR
kit (Applied Biosystems, Foster City, CA, USA). Ampli¢cation of
hNMT1, hNMT2, HIV-1, and L-actin sequences by PCR using Ampli
Taq Gold (Applied Biosystems, Foster City, CA, USA) was carried
out in a thermal cycler using the following protocol: one cycle at 94‡C
for 9 min; 33 cycles at 94‡C for 1 min, 60‡C for 1 min, and 72‡C for
1 min; and one cycle at 72‡C for 5 min. The oligonucleotide primers
used for the PCR were as follows: NMT1 sense primer CCGCAGAT-
GATGGAAGGGAA; NMT1 antisense primer CCTCTCTGCTGG-
CAAAGAGTTCA; NMT2 sense primer GAAGTCCTGGAGGGT-
ATTTG; NMT2 antisense primer CTGCATTGGAACACTGGGA-
TT; SK38 (HIV-1gag) ATAATCCACCTATCCCAGTAGGAGAA-
AT; SK39 (HIV-1gag) TTTGGTCCTTGTCTTATGTCCAGAATG-
C; L-actin CGGAACCGCTCATTGCC; L-actin ACCCACATCGT-
GCCCATCTA. The PCR products were separated by 2% agarose gel
electrophoresis and visualized by ethidium bromide staining. The den-
sity of each product was semiquanti¢ed using the luminoimage ana-
lyzer LAS-1000 plus (Fuji ¢lm). Each RNA value was expressed as
percentage of the value of the uninfected CEM cells.
2.6. Fluorography
COLO320DM cells were metabolically labeled for 24 h with 10 WCi/
ml [9,10-3H]myristic acid (NEN Research Products) in the presence or
absence of serinal derivatives. After radiolabeling, the cells were
washed twice with PBS(^) and lysed in lysis bu¡er (50 mM Tris^
HCl [pH 7.4], 150 mM NaCl, 1% Triton X-100, 1% sodium deoxy-
cholate, 0.1% SDS, 1 mM PMSF, 50 Wg/ml each of antipain, leupep-
tin, pepstatin A, and aprotinin). The cell lysates were subjected to
SDS^PAGE followed by £uorography.
2.7. Cytotoxicity
A cytotoxicity test of serinal derivatives was performed as previ-
ously described [18].
3. Results and discussion
The alteration of host gene expression occurs after HIV-1
infection, with several reports on the investigation of the
mRNA level [22^24]. Previously, we reported that the expres-
sion levels of hNMTs in CEM cells decreased in the course of
HIV-1 infection. To investigate the change of the mRNA ex-
pression levels of hNMT isoforms, hNMT1 and hNMT2,
acute HIV-1 (LAV-1 strain)-infected CEM cells were cultured
for 0, 24, 48, 72, or 96 h. The acute HIV-1-infected cells and
chronic HIV-1-infected CEM cells, CEM/LAV-1, were har-
vested and the total RNAs were extracted, followed by reverse
transcription to cDNA. Using speci¢c primer pairs for the
ampli¢cation of cDNA from hNMT1, hNMT2, HIV-1 and
actin mRNA, semiquantitative PCR was performed as de-
scribed in Section 2. As shown in Fig. 1A, the densities of
the ampli¢ed 289 bp band from L-actin mRNA were similar
in the course of infection. The ratio of the density of the band
from hNMT1 (214 bp) or hNMT2 (157 bp) mRNA to that of
the band from actin mRNA at the corresponding time was
expressed as percentage of that of uninfected CEM (at 0 h
postinfection). As shown in Fig. 1B, a decrease in both the
hNMT1 and hNMT2 mRNA levels was observed in the
course of infection. The hNMT1 and hNMT2 mRNA levels
of CEM/LAV-1 were approximately half of those of CEM.
Fig. 1. NMT level in HIV-1-infected CEM. A: CEM cells were in-
fected with HIV-1 (LAV-1 strain) at an m.o.i. of 0.25 and cultured
for 0, 24, 48, 72, or 96 h. Acute HIV-1-infected CEM cells and
chronic HIV-1-infected CEM cells, CEM/LAV-1, were harvested.
The total RNAs were extracted, followed by reverse transcription to
cDNA. Using speci¢c primer pairs for the ampli¢cation of cDNA
from hNMT1, hNMT2, HIV-1 and actin mRNA, semiquantitative
PCR was performed as described in Section 2. Representative re-
sults are shown. B: The ratio of the density of the band from
hNMT1 or hNMT2 mRNA to that of the band from actin mRNA
at the corresponding time was expressed as the percentage of that
of uninfected CEM cells (at 0 h postinfection). Open column,
NMT1 mRNA; closed column, NMT2 mRNA. C: CEM cells were
infected with HIV-1 (LAV-1 strain) at an m.o.i. of 0.25 and cul-
tured for 0, 24, 48, 72, or 96 h. The cells were lysed and subjected
to NMT^ELISA using the peptide substrate of synthetic biotinyl-
ated Gly-Ser-Ser-Lys-Ser-Lys-Pro-Lys. Signi¢cant di¡erences from
CEM as determined by Student’s t-test are noted as follows:
*P6 0.05.
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On the other hand, the band from HIV-1 mRNA (115 bp)
was detected weakly at 24 h postinfection and strongly at 48^
96 h postinfection and its density was higher than that of
CEM/LAV-1 (Fig. 1A).
Moreover, we evaluated NMT activities of the cells in the
course of infection by NMT^ELISA [21]. The assay can detect
the NMT activity in CEM lysate quantitatively (data not
shown). NMT activity was expressed as percentage of that
of uninfected CEM. As shown in Fig. 1C, partially decreased
NMT activity was observed from 48 to 96 h postinfection,
and was signi¢cant (P6 0.05) at 96 h postinfection. These
results indicate that the expression levels of hNMTs decreased
due to HIV-1 infection. It is also strongly suggested that the
decrease of NMT expression in levels in both mRNA and
protein [17] is closely related to the decrease in the NMT
activity. Therefore, it is thought that chronically infected
CEM with weak expression of NMT would cause a decrease
in NMT activity. The event with HIV-1 infection was of in-
terest to us because NMT is thought to be essential for both
HIV-1 and the host. HIV-1 gene products namely, p17gag and
Nef, are N-myristoylated, which is important for tra⁄cking to
and associating with lipid rafts [25] or raft-like membrane
microdomains called barge [26]. In the host cell, many
N-myristoylated proteins participate in the signal transduction
pathway, vesicular tra⁄cking, cell survival, and regulation of
cytoskeletal assembly [27]. We hypothesized that the decrease
in the expression level of NMT due to HIV-1 infection may be
related to the mechanism of viral latent replication [17],
although it has not been proven yet.
Protein N-myristoylation appears to be limited to eukary-
otes. Studies of NMT inhibitors as anti-fungal agents are well
known [28^30]. It is, therefore, thought to be inevitable that
NMT inhibitors induce lethal damage of eukaryotic-cell-con-
taining mammalian cells. Although it is still unknown whether
this partial down-regulation of hNMTs with HIV-1 infection
is advantageous or disadvantageous for HIV-1 and the host
cell, complete or marked suppression of NMT activity by the
addition of an NMT inhibitor has a lethal e¡ect on the HIV-
1-infected host cell. Furthermore, it is expected that the con-
centration of the NMT inhibitor that will exert a lethal e¡ect
on an infected cell is lower than that for an uninfected cell.
As a candidate NMT inhibitor, serinal derivatives [18] were
synthesized. The in vivo inhibitory activity of the serinal de-
rivatives on NMT was tested. The human colon adenocarci-
noma cell line COLO320DM was metabolically labeled for
24 h with [9,10-3H]myristic acid in the presence or absence
of serinal derivatives. The cells were lysed and subjected to
SDS^PAGE, followed by £uorography to detect radiolabeled
N-myristoylated proteins. As shown in Fig. 2, a number of
N-myristoylated proteins were detected in control cell lysate
(lanes 1 and 3), whereas only a few or no proteins were de-
tected in cell lysates treated with N-myristoyl serinal bisul¢te
(lane 2), O-myristoyl serinal bisul¢te (lane 4), and N-acetyl-O-
myristoyl serinal diethylacetal (lane 6) at 100 WM. In vitro
enzyme assay revealed that these derivatives inhibited NMT
activity (data not shown). In the case of treatment with
N-acetyl-O-palmitoyl serinal diethylacetal (lane 5), the inhib-
itory e¡ect of N-myristoylation was not observed. In this as-
say, the cytotoxicity of serinal derivatives to COLO320DM
was not observed.
The cytotoxic e¡ects of the four serinal derivatives on CEM
and CEM/LAV-1 cells were evaluated. The cells were cultured
in the presence or absence of the derivatives for 96 h. The
number of viable cells was determined by the trypan blue dye
exclusion method. Cell viability was expressed as percentage
of the control. As shown in Fig. 3, the three serinal derivatives
with NMT inhibitory e¡ect, O-myristoyl serinal bisul¢te (Fig.
3A), N-acetyl-O-myristoyl serinal diethylacetal (Fig. 3B), and
N-myristoyl serinal bisul¢te (Fig. 3C) showed cytotoxic e¡ect
on both CEM and CEM/LAV-1 cells, with the e¡ect being
signi¢cantly intense on CEM/LAV-1 cells, although the selec-
tivity indexes are still low (the values were 6 6). On the other
hand, the serinal derivative with no inhibitory e¡ect on NMT,
N-acetyl-O-palmitoyl serinal diethylacetal, did not in£uence
the viability of both CEM and CEM/LAV-1 cells. The results
suggest that one of the mechanisms of the selective cytotox-
icity to CEM/LAV-1 cells of the serinal derivatives is the
marked inhibition of NMT activity in CEM/LAV-1 cells in
contrast to the partial inhibition of the same in CEM cells at a
concentration that exhibit a signi¢cant and selective cytotoxic
e¡ect.
Now, emergence of a drug-resistant virus could arise with
treatment failure [31]. The ultimate objective of HIV-1 ther-
apy should be the eradication of viral reservoirs. The proposal
of NMT as a candidate target for the infected-cell-selective
cytotoxic e¡ect is therefore very signi¢cant, although it re-
mains to be con¢rmed whether the selective cytotoxic e¡ect
can be applied in the case of combination of other kinds of
HIV-1 strains and host cells. There are several isoforms of
hNMT, including at least the hNMT1 short form, hNMT1
long form [32], and hNMT2 [33]. In addition, there are a
number of N-myristoylated proteins [27]. It has been unclear
which NMT isoform and which NMT substrate is related to
cell survival or death in the T-cell line. Clari¢cation of the
detailed mechanism would contribute to the development of
more e¡ective and more speci¢c anti-HIV-1-infected cell
agents.
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